233 related articles for article (PubMed ID: 29234821)
1. [Neuroendocrine tumors of the abdomen].
Juchems M
Radiologe; 2018 Jan; 58(1):36-44. PubMed ID: 29234821
[TBL] [Abstract][Full Text] [Related]
2. Gastroenteropancreatic Neuroendocrine Tumors-Current Status and Advances in Diagnostic Imaging.
Vogele D; Schmidt SA; Gnutzmann D; Thaiss WM; Ettrich TJ; Kornmann M; Beer M; Juchems MS
Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685279
[TBL] [Abstract][Full Text] [Related]
3. [Neuroendocrine tumors of the pancreas].
Juchems M; Kläsner B
Radiologie (Heidelb); 2023 Dec; 63(12):894-899. PubMed ID: 37947864
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Management of Gastroenteropancreatic Neuroendocrine Neoplasms: Technique Optimization and Tips and Tricks for Radiologists.
Pellegrino F; Granata V; Fusco R; Grassi F; Tafuto S; Perrucci L; Tralli G; Scaglione M
Tomography; 2023 Jan; 9(1):217-246. PubMed ID: 36828370
[TBL] [Abstract][Full Text] [Related]
5. [Gastroenteropancreatic endocrine tumors].
Schmid-Tannwald C; Schmid-Tannwald CM; Reiser MF; Berger F
Radiologe; 2014 Oct; 54(10):989-97. PubMed ID: 25234769
[TBL] [Abstract][Full Text] [Related]
6. [Modern sonographic imaging of abdominal neuroendocrine tumors].
Schwarze V; Marschner C; Grosu S; Rübenthaler J; Knösel T; Clevert DA
Radiologe; 2019 Nov; 59(11):1002-1009. PubMed ID: 31440790
[TBL] [Abstract][Full Text] [Related]
7. Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - Imaging and staging.
Baumann T; Rottenburger C; Nicolas G; Wild D
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):45-57. PubMed ID: 26971843
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
[TBL] [Abstract][Full Text] [Related]
9. [Contemporary nuclear medicine diagnostics of neuroendocrine tumors].
Srp Arh Celok Lek; 2015; 143(1-2):108-15. PubMed ID: 25845263
[TBL] [Abstract][Full Text] [Related]
10. Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology.
Kidd M; Modlin IM; Bodei L; Drozdov I
Cell Mol Gastroenterol Hepatol; 2015 Mar; 1(2):131-153. PubMed ID: 28210673
[TBL] [Abstract][Full Text] [Related]
11. [Neuroendocrine tumors of the stomach, duodenum and pancreas : Value of (hybrid) radiological diagnostics].
Rübenthaler J; Auernhammer C; Harun I; Ricke J; Cyran CC
Radiologe; 2019 Nov; 59(11):961-967. PubMed ID: 31515568
[TBL] [Abstract][Full Text] [Related]
12. [Pancreatic neuroendocrine neoplasms].
Beiderwellen K; Sabet A; Lauenstein TC; Lahner H; Poeppel TD
Radiologe; 2016 Apr; 56(4):348-54. PubMed ID: 27003413
[TBL] [Abstract][Full Text] [Related]
13. Radiology of the neuroendocrine neoplasms of the gastrointestinal tract: a comprehensive review.
Malla S; Kumar P; Madhusudhan KS
Abdom Radiol (NY); 2021 Mar; 46(3):919-935. PubMed ID: 32960304
[TBL] [Abstract][Full Text] [Related]
14. Prospective comparison of whole-body MRI with diffusion-weighted and conventional imaging for the follow-up of neuroendocrine tumors.
Minon M; Soriano C; Morland D; Walter T; Lepage C; Tabarin A; Deblock M; Rousset P; Barbe C; Hoeffel C; Cadiot G
Endocrine; 2020 Jan; 67(1):243-251. PubMed ID: 31564038
[TBL] [Abstract][Full Text] [Related]
15. Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study.
Carlsen EA; Fazio N; Granberg D; Grozinsky-Glasberg S; Ahmadzadehfar H; Grana CM; Zandee WT; Cwikla J; Walter MA; Oturai PS; Rinke A; Weaver A; Frilling A; Gritti S; Arveschoug AK; Meirovitz A; Knigge U; Sorbye H
Endocr Relat Cancer; 2019 Feb; 26(2):227-239. PubMed ID: 30540557
[TBL] [Abstract][Full Text] [Related]
16. Integrating Functional Imaging and Molecular Profiling for Optimal Treatment Selection in Neuroendocrine Neoplasms (NEN).
Kong G; Boehm E; Prall O; Murray WK; Tothill RW; Michael M
Curr Oncol Rep; 2023 May; 25(5):465-478. PubMed ID: 36826704
[TBL] [Abstract][Full Text] [Related]
17. The Correlation Between [
Yu J; Li N; Li J; Lu M; Leal JP; Tan H; Su H; Fan Y; Zhang Y; Zhao W; Zhu H; Pomper MG; Zhou Y; Yang Z
Mol Imaging Biol; 2019 Oct; 21(5):984-990. PubMed ID: 30796708
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography.
Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L
Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904
[TBL] [Abstract][Full Text] [Related]
19. Fast non-enhanced abdominal examination protocols in PET/MRI for patients with neuroendocrine tumors (NET): comparison to multiphase contrast-enhanced PET/CT.
Seith F; Schraml C; Reischl G; Nikolaou K; Pfannenberg C; la Fougère C; Schwenzer N
Radiol Med; 2018 Nov; 123(11):860-870. PubMed ID: 29961229
[TBL] [Abstract][Full Text] [Related]
20. [Imaging of neuroendocrine tumors of the gastrointestinal tract : Value of (hybrid) imaging diagnostics in radiology].
Ebner R; Rübenthaler J; Ricke J; Sheikh GT; Unterrainer LM; Auernhammer CJ; Spitzweg C; Brendel M; Schmid-Tannwald C; Cyran CC
Radiologie (Heidelb); 2024 May; ():. PubMed ID: 38713221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
